One of the essential parts of the mission of The Developmental Therapeutic Program (DTP) of the Division of Cancer Treatment and Diagnosis (DCTD) is involved in discovery and development of new therapeutic agents and the manufacture and supply of dosage forms to support human clinical trials under the NCI sponsorship or through investigator initiated INDs. Molecules for development enter the system under various mechanisms such as NCI Experimental Therapeutics Program (NExT) or ?Joint Development? programs. The contract provides the NCI with pharmaceutical development and production of oral and topical dosage forms for use in clinical trials, advanced Pharmacology, and IND directed Toxicology testing.

Agency
National Institute of Health (NIH)
Type
Resource and Support Contracts (N02)
Project #
261201000023C-7-0-1
Application #
8605136
Study Section
Project Start
2010-07-01
Project End
2015-06-30
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$283,206
Indirect Cost
Name
Irisys, Inc.
Department
Type
DUNS #
959205568
City
San Diego
State
CA
Country
United States
Zip Code
92121